Could a simple blood test predict pancreatic cancer survival?
NCT ID NCT07091526
Summary
This study looks back at medical records to see if controlling uric acid levels in the blood after pancreatic cancer surgery helps patients live longer. Researchers are analyzing data from 168 patients who had their pancreatic tumors surgically removed. The goal is to understand if managing this common blood marker could be a new way to improve outcomes for people with this serious cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SERUM URIC ACID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hepatopancreatobiliary Surgery Institute of Gansu Province
RECRUITINGLanzhou, Gansu, 730000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.